Recommendations for Providing Dialysis Treatment to Patients Infected with Human T-Lymphotropic Virus Type lll/Lymphadenopathy-Associated Virus
Journal: Annals of Internal Medicine (1986)

Diagnosis and Treatment1 October 1986Recommendations for Providing Dialysis Treatment to Patients Infected with Human T-Lymphotropic Virus Type lll/Lymphadenopathy-Associated VirusAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-105-4-558 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail AbstractAbstractMaintenance dialysis can be continued in patients with end-stage renal disease who have manifestations of human T-lymphotropic virus type lll/lymphadenopathyassociated virus (HTLV-III/LAV) [now known as the human immunodeficiency virus], including the acquired immunodeficiency syndrome, or who are positive for antibody to HTLV-III/LAV. These patients can be dialyzed in hospital-based or free-standing dialysis units using conventional infection-control precautions. Transmission of HTLV-III/LAV is adequately prevented by standard blood and body fluid precautions, and disinfection and sterilization procedures.References1. CURRANEVATTLAWRENCE JBD. Acquired immune deficiency syndrome: the past as prologue. Ann Intern Med. 1983;98:401-2. LinkGoogle Scholar2. FAVERO M. Recommended precautions for patients undergoing hemodialysis who have AIDS or non-A, non-B hepatitis. Infect Control. 1985;6:301-5. CrossrefMedlineGoogle Scholar3. PETERMANLANGMIKOS TGN. HTLV-III/LAV infection in hemodialysis patients. JAMA. 1986;255:2324-6. CrossrefMedlineGoogle Scholar4. . Summary: recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace. MMWR. 1985;34:681. MedlineGoogle Scholar5. FAVERO M. Dialysis-associated diseases and their control. In: Bennett JV, Brachman PS, eds. Hospital Infections. Boston: Little, Brown and Company, Inc.; 1985:267-84. Google Scholar6. . Hepatitis—control measures for hepatitis B in dialysis centers. Viral hepatitis: Atlanta, Georgia: Center for Disease Control; 1977: HEW publication no. (CDC)78-8358 (Investigation and control series, November 1977). Google Scholar7. . Hepatitis surveillance report no. 49. Issued January 1985:3-4. Google Scholar8. GARNERSIMMONS JB. CDC guideline for isolation precautions in hospitals. Infect Control. 1983;5:245-325. Google Scholar9. . Update: Public Health Service workshop on human T-lymphotropic virus type III antibody testing-United States. MMWR. 1985;34:477-8. MedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: ▸From the Centers for Disease Control; Atlanta, Georgia. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byHuman Immunodeficiency Virus-Associated Nephropathy: Current ConceptsRecurrence and Clearance of Hepatitis B Surface Antigenemia in a Dialysis Patient Infected With the Human Immunodeficiency VirusContinuous Ambulatory Peritoneal Dialysis for the AIDS PatientRecovery of HIV Antigen in Peritoneal Dialysis FluidTransmission du VIH aux personnels des services de reanimationPrevalence of HTLV-1 Antibodies in Hemodialysis Patients in JapanFalse-Positive Results of Screening for Antibodies to Human Immunodeficiency Virus in Chronic Hemodialysis Patients 1 October 1986Volume 105, Issue 4Page: 558-559KeywordsAIDSBloodBody fluidsDisinfectionHIVHuman t lymphotropic virusInfectious disease controlMedical dialysisPatientsRenal failure ePublished: 1 December 2008 Issue Published: 1 October 1986 PDF downloadLoading ...